HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: M300275-JLR200v1 45/1/155    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chen, Z. Articles by Schonfeld, G. Search for Related Content PubMed PubMed Citation Articles by Chen, Z. Articles by Schonfeld, G. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 45, 155-163, January 2004
Copyright © 2004 by American Society for Biochemistry and Molecular Biology

Hepatic secretion of apoB-100 is impaired in hypobetalipoproteinemic mice with an apoB-38.9-specifying allele

Zhouji Chen^1,*, Robin L. Fitzgerald^*, Gang Li^2,*, Nicholas O. Davidson and Gustav Schonfeld^*

^* Divisions of Atherosclerosis, Nutrition, and Lipid Research, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110
Gastroenterology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110

¹ To whom correspondence should be addressed. e-mail: zchen{at}im.wustl.edu

Apolipoprotein B (apoB) truncation-specifying mutations cause familial hypobetalipoproteinemia (FHBL). Lipoprotein kinetics studies have shown that production rates of apoB-100 are reduced by 70–80% in heterozygous FHBL humans, instead of the expected 50%. To develop suitable mouse models to study the underlying mechanism, apoB-38.9-only (Apob^38.9/38.9) mice were crossbred with Apobec-1 knockout (Apobec-1^-/-) mice or apoB-100-only (Apob^100/100) mice to produce two lines of apoB-38.9 heterozygous mice that produce only apoB-38.9 and apoB-100, namely Apobec-1^-/-/Apob^38.9/+ and Apob^38.9/100 mice. In vivo rates of apoB-100 secretion were measured using [³⁵S]Met/Cys to label proteins and Triton WR-1339 to block apoB-100 VLDL lipolysis/uptake. Rates of secretion were reduced by 80%, rather than the expected 50%, in both Apobec-1^-/-/Apob^38.9/+ and Apob^38.9/100 mice compared with those of the respective Apobec-1^-/-/Apob^+/+ and Apob^100/100 control mice. Continuous labeling and pulse-chase experiments in primary hepatocyte cultures revealed that rates of apoB-100 synthesis by Apobec-1^-/-/Apob^38.9/+ and Apob^38.9/100 hepatocytes were reduced to the expected 50% of those of the respective controls, but the efficiency of secretion of apoB-100 was significantly lower in apoB-38.9 heterozygous hepatocytes.

The greater-than-expected decreases in apoB-100 production rates of FHBL heterozygous humans appear to be attributable to a defect in secretion rather than in the synthesis of apoB-100 from the unaffected apoB allele.

Supplementary key words VLDL secretion • gene targeting • animal model

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				Z. Chen, E. P. Newberry, J. Y. Norris, Y. Xie, J. Luo, S. M. Kennedy, and N. O. Davidson ApoB100 is required for increased VLDL-triglyceride secretion by microsomal triglyceride transfer protein in ob/ob mice J. Lipid Res., September 1, 2008; 49(9): 2013 - 2022. [Abstract] [Full Text] [PDF]

				P. Degrace, L. Demizieux, Z.-y. Du, J. Gresti, L. Caverot, L. Djaouti, T. Jourdan, B. Moindrot, J.-C. Guilland, J.-F. Hocquette, et al. Regulation of Lipid Flux between Liver and Adipose Tissue during Transient Hepatic Steatosis in Carnitine-depleted Rats J. Biol. Chem., July 20, 2007; 282(29): 20816 - 20826. [Abstract] [Full Text] [PDF]

				R. R. Sankatsing, S. W. Fouchier, S. de Haan, B. A. Hutten, E. de Groot, J. J.P. Kastelein, and E. S.G. Stroes Hepatic and Cardiovascular Consequences of Familial Hypobetalipoproteinemia Arterioscler. Thromb. Vasc. Biol., September 1, 2005; 25(9): 1979 - 1984. [Abstract] [Full Text] [PDF]

				A. J. Whitfield, P. H. R. Barrett, F. M. van Bockxmeer, and J. R. Burnett Lipid Disorders and Mutations in the APOB Gene Clin. Chem., October 1, 2004; 50(10): 1725 - 1732. [Abstract] [Full Text] [PDF]

				J. R. Garbow, X. Lin, N. Sakata, Z. Chen, D. Koh, and G. Schonfeld In vivo MRS measurement of liver lipid levels in mice J. Lipid Res., July 1, 2004; 45(7): 1364 - 1371. [Abstract] [Full Text] [PDF]